Hennion & Walsh Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.76M Buy
155,961
+44,855
+40% +$507K 0.07% 339
2025
Q1
$1.28M Buy
111,106
+36,279
+48% +$419K 0.06% 409
2024
Q4
$634K Buy
+74,827
New +$634K 0.03% 573